The global erectile dysfunction drugs market was valued at USD 3.0 billion in 2022, growing at a CAGR of 9% from 2023 to 2032. The market is expected to reach USD 7.1 billion by 2032. Patient awareness and knowledge are increasing, as is the ageing population. The rising prevalence of lifestyle diseases and the increasing adoption of sedentary lifestyles drive the growth of the erectile dysfunction drugs market.
Erectile dysfunction is the inability to acquire or maintain a hard enough erection for sexual contact. It's sometimes known as impotence. However, this phrase is becoming less popular. It is not unusual to experience rare erectile dysfunction. Many guys suffer from it when they are under stress. Regular erectile dysfunction might indicate underlying health issues that must be addressed. It may also signal emotional or relationship issues that require the assistance of a professional. Erectile dysfunction can occur due to problems at any stage of the erection procedure. An erection is caused by increased blood flow to the penis. Sexual ideas or a direct connection with the penis frequently cause blood flow. When a man feels sexually excited, his penile muscles relax, which boosts blood flow through the penile arteries, which serve two chambers inside the penis. The penis rigidly expands as the chambers fill with blood. An erection ends when the muscles contract, and the blood gathered can flow out through the penile veins. The doctor may recommend medication to assist you in managing your erectile dysfunction symptoms. They administer medication to patients after consulting with the doctor. There are various treatments on the market, but a doctor must prescribe them; one of the medications is Alprostadil, which treats erectile dysfunction. It comes in two forms: a penile suppository and a self-injection at the base or flank of the penis. If testosterone levels are low, the doctor may offer testosterone therapy (TRT), one of the drugs available on the market, based on the doctor's prescriptions.
Get an overview of this study by requesting a free sample
In September 2021, iX Biopharma inked an agreement with CRPCG through its wholly-owned subsidiary for the licencing, supply, and sale of Wafesil, a sublingual sildenafil wafer for the treatment of male erectile dysfunction, in China.
Almus announced the release of Almus Erectile Dysfunction Relief 50mg Film-Coated Tablets to the UK pharmaceutical market in September 2021.
Launch Medical and GAINSWave announced the settlement of their lawsuit in June 2020. They began collaborating to commercialise The Phoenix, a new home-use acoustic wave gadget for treating erectile dysfunction.
Glenmark Pharma gained final approval from the US Food and Drug Administration for Tadalafil pills, used to treat erectile dysfunction and enlarged prostate, in December 2020.
Rising Popularity of Nicotine- The global demand for erectile dysfunction drugs is increasing due to an ageing population and a high prevalence of chronic conditions such as kidney failure, hormonal imbalance, diabetes, hypertension, and neurological problems. Furthermore, increased patient awareness of erectile dysfunction and the availability of treatment contribute considerably to the global growth of the erectile dysfunction drug market.
Patent Expiration- The global market is declining due to the patent expiration of significant blockbuster pharmaceuticals such as Viagra.
Generic Manufacturers- The patent expiration of big brands presents a significant opportunity for generic manufacturers to enter the erectile dysfunction drugs market. Furthermore, players at various stages of the market are expected to generate significant opportunities for the global erectile dysfunction drugs market.
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest market for the global erectile dysfunction drugs market, with a 55% market revenue share in 2022.
North America is predicted to lead the erectile dysfunction drugs market, owing to an ageing population, increased ED cases, and superior healthcare infrastructure. According to an MSD Manuals article published in September 2022, approximately 50% of males aged 40 to 70 are affected by ED, and the percentage rises with age. Furthermore, according to a National Institute of Diabetes and Digestive and Kidney Diseases report, ED will impact nearly 30 million men in the United States by 2021. Furthermore, the country has the highest rate of self-reported ED, which will drive market expansion during the forecast period.
Furthermore, studies and product launches to effectively treat ED fuel market expansion. Petros Pharmaceuticals, Inc., for example, launched two self-selection studies for its erectile dysfunction (ED) medicine, STENDRA (avanafil), in January 2022. Furthermore, Lupin Limited received FDA approval to market Sildenafil for oral suspension, 10 mg/mL, in September 2022. Such developments are propelling the market.
North America Region Erectile Dysfunction Drugs Market Share in 2022 - 55%
Check the geographical analysis of this market by requesting a free sample
The product segment is divided into viagra, cialis, levitra/staxyn, stendra/spedra, zydena, vitaros, and others. The viagra segment dominated the market, with a market share of around 37% in 2022. Many businesses are pursuing numerous strategic initiatives such as research collaboration, collaborations, and agreements to increase their corporate presence. For example, Pfizer, Inc. and Digital Men's Clinic Roman entered a supply agreement in January 2020 to provide a generic form of Viagra to Roman members. This supply deal is likely to support the segment's growth.
|Market Size||Revenue (USD Billion)|
|Market size value in 2022||USD 3.0 Billion|
|Market size value in 2032||USD 7.1 Billion|
|CAGR (2023 to 2032)||9%|
|Region||The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.|
As per The Brainy Insights, the size of the erectile dysfunction drugs market was valued at USD 3.0 billion in 2022 to USD 7.1 billion by 2032.
The global erectile dysfunction drugs market is growing at a CAGR of 9% during the forecast period 2023-2032.
North America emerged as the largest erectile dysfunction drugs market.
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis by Product
4.3.2. Market Attractiveness Analysis by Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2.1. Rising popularity of nicotine
5.3.1. Patent expiration
5.4.1. Generic manufacturers
5.5.1. Patient unwillingness
6. Global Erectile Dysfunction Drugs Market Analysis and Forecast, By Product
6.1. Segment Overview
7. Global Erectile Dysfunction Drugs Market Analysis and Forecast, By Regional Analysis
7.1. Segment Overview
7.2. North America
7.5. South America
7.6. Middle East and Africa
7.6.2. South Africa
8. Global Erectile Dysfunction Drugs Market-Competitive Landscape
8.2. Market Share of Key Players in Global Erectile Dysfunction Drugs Market
8.2.1. Global Company Market Share
8.2.2. North America Company Market Share
8.2.3. Europe Company Market Share
8.2.4. APAC Company Market Share
8.3. Competitive Situations and Trends
8.3.1. Product Launches and Developments
8.3.2. Partnerships, Collaborations, and Agreements
8.3.3. Mergers & Acquisitions
9. Company Profiles
9.1. Pfizer Inc.
9.1.1. Business Overview
9.1.2. Company Snapshot
9.1.3. Company Market Share Analysis
9.1.4. Company Product Portfolio
9.1.5. Recent Developments
9.1.6. SWOT Analysis
9.2. Eli Lilly and Company
9.2.1. Business Overview
9.2.2. Company Snapshot
9.2.3. Company Market Share Analysis
9.2.4. Company Product Portfolio
9.2.5. Recent Developments
9.2.6. SWOT Analysis
9.3. Teva Pharmaceutical Industries Ltd
9.3.1. Business Overview
9.3.2. Company Snapshot
9.3.3. Company Market Share Analysis
9.3.4. Company Product Portfolio
9.3.5. Recent Developments
9.3.6. SWOT Analysis
9.4.1. Business Overview
9.4.2. Company Snapshot
9.4.3. Company Market Share Analysis
9.4.4. Company Product Portfolio
9.4.5. Recent Developments
9.4.6. SWOT Analysis
9.5. Sun Pharmaceutical Industries Ltd
9.5.1. Business Overview
9.5.2. Company Snapshot
9.5.3. Company Market Share Analysis
9.5.4. Company Product Portfolio
9.5.5. Recent Developments
9.5.6. SWOT Analysis
9.6. Bayer AG
9.6.1. Business Overview
9.6.2. Company Snapshot
9.6.3. Company Market Share Analysis
9.6.4. Company Product Portfolio
9.6.5. Recent Developments
9.6.6. SWOT Analysis
9.7. Petros Pharmaceuticals, Inc.
9.7.1. Business Overview
9.7.2. Company Snapshot
9.7.3. Company Market Share Analysis
9.7.4. Company Product Portfolio
9.7.5. Recent Developments
9.7.6. SWOT Analysis
9.8. VIVUS, Inc.
9.8.1. Business Overview
9.8.2. Company Snapshot
9.8.3. Company Market Share Analysis
9.8.4. Company Product Portfolio
9.8.5. Recent Developments
9.8.6. SWOT Analysis
9.9. Auxilium Pharmaceuticals, Inc.
9.9.1. Business Overview
9.9.2. Company Snapshot
9.9.3. Company Market Share Analysis
9.9.4. Company Product Portfolio
9.9.5. Recent Developments
9.9.6. SWOT Analysis
9.10.1. Business Overview
9.10.2. Company Snapshot
9.10.3. Company Market Share Analysis
9.10.4. Company Product Portfolio
9.10.5. Recent Developments
9.10.6. SWOT Analysis
List of Table
1. Global Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
2. Global Viagra, Erectile Dysfunction Drugs Market, By Region, 2019-2032 (USD Billion)
3. Global Cialis, Erectile Dysfunction Drugs Market, By Region, 2019-2032 (USD Billion)
4. Global Levitra/Staxyn, Erectile Dysfunction Drugs Market, By Region, 2019-2032 (USD Billion)
5. Global Stendra/Spedra, Erectile Dysfunction Drugs Market, By Region, 2019-2032 (USD Billion)
6. Global Zydena, Erectile Dysfunction Drugs Market, By Region, 2019-2032 (USD Billion)
7. Global Vitaros, Erectile Dysfunction Drugs Market, By Region, 2019-2032 (USD Billion)
8. Global Others, Erectile Dysfunction Drugs Market, By Region, 2019-2032 (USD Billion)
9. North America Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
10. U.S. Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
11. Canada Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
12. Mexico Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
13. Europe Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
14. Germany Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
15. France Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
16. U.K. Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
17. Italy Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
18. Spain Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
19. Asia Pacific Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
20. Japan Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
21. China Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
22. India Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
23. South America Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
24. Brazil Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
25. Middle East and Africa Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
26. UAE Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
27. South Africa Erectile Dysfunction Drugs Market, By Product, 2019-2032 (USD Billion)
List of Figures
1. Global Erectile Dysfunction Drugs Market Segmentation
2. Global Erectile Dysfunction Drugs Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Erectile Dysfunction Drugs Market Attractiveness Analysis by Product
9. Global Erectile Dysfunction Drugs Market Attractiveness Analysis by Region
10. Global Erectile Dysfunction Drugs Market: Dynamics
11. Global Erectile Dysfunction Drugs Market Share by Product (2023 & 2032)
12. Global Erectile Dysfunction Drugs Market Share by Regions (2023 & 2032)
13. Global Erectile Dysfunction Drugs Market Share by Company (2022)
This study forecasts global, regional, and country revenue from 2019 to 2032. The Brainy Insights has segmented the global erectile dysfunction drugs market based on the below-mentioned segments:
Global Erectile Dysfunction Drugs Market By Product:
Global Erectile Dysfunction Drugs Market By Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date